Hints and tips:
Related Special Reports
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...“Private equity continues to have a love affair with pharma-adjacent suppliers,” said Robert Darwin, a partner at law firm Sidley Austin and specialist in life sciences transactions....
...Diaceutics, a precision medicine diagnostics group, is doing just that....
...Leqembi slowed cognitive decline by 27 per cent compared with the placebo group in a phase 3 trial....
...The positive data will also be a boon to Eli Lilly’s efforts to push for more widescale coverage of the drugs by private insurers and US federal health insurance programme Medicare, which were both initially...
...Deaths from the condition have fallen in most high-income states over the past 30 years, partly reflecting public health campaigns and increased testing....
...Nearly seven men out of every 1,000 in the group invited for screening had died from prostate cancer, compared with nearly eight men out of every 1,000 in the group which had not....
...The Group for Equity, made up of Asian, African and Latin American countries, wants firm rules in place....
...According to a poll published last month by Opinium on behalf of the campaign group Dignity in Dying, 75 per cent of people living in the UK support assisted dying....
...World Health Organization member states started the last round of talks on the accord on Monday....
...Pfizer and BioNTech will dispute Moderna’s ability to withdraw the pledge when it did, given the World Health Organization did not declare the end of the “global health emergency” until March 2023....
...Orchard’s MLD treatment was given list prices of up to $3.9mn when it was approved across Europe in 2020 under the brand name Libmeldy, but national health systems negotiated steep discounts....
...The risks faced by the group of people Nyborg wants to target are serious....
...The results will renew attention on the possible effectiveness of lixisenatide, which is made by French pharmaceutical group Sanofi, and other so-called GLP-1 drugs against neurodegenerative conditions....
...The writer is a science commentator Four years ago this week, the World Health Organization declared the rapid spread of a new coronavirus to be a pandemic....
...AMR, largely caused by excessive use of antibiotics, is already linked to 5mn deaths a year, according to the World Health Organization....
...A study published last month pointed to changes in the “complement system”, a group of proteins that help the body fight infections....
...This month Brazil started distributing a vaccine produced by Japanese pharmaceutical group Takeda....
...But four years after the outbreak of Covid-19, Mona Nemer, the chair of the mission’s steering group, said pandemic preparedness was being taken “for granted”....
...Although the 21.1 per cent uptake of the GSK and Pfizer jabs is comfortably ahead of the 18 per cent forecast by health data provider Airfinity, GSK’s Arexvy jab has accounted for more than two-thirds of...
...The pandemic, which created what Miller describes as a “utilitarian” need for reliable health information, is likely to have pushed science higher up the average American’s agenda; the more salient an issue...
...The group of 10 patients experienced a 95 per cent reduction in attacks on average after receiving the treatment, the study found....
...The biotech group’s investors for this funding round include MSD GHIF, an investment arm of US pharma company MSD, along with UK venture capital group IQ Capital....
...The central finding of the research, published in Science on Thursday, is the importance of the “complement system” — a group of proteins that collectively helps the body fight off infections, but whose...
...A decade later, that difference had reached more than two-thirds, the group said. “Europe is losing R&D....
International Edition